Athletigen Stock
Leading Genetics testing for Athletic and Sport potential
Sign up today and learn more about Athletigen Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Athletigen Stock
Athletigen is the world's leading Genetics testing company for athletes of all types (professional, elite, collegiate, recreational) to determine an individual's genetically determined athletic potential. For a $199 test using a saliva sample, which you can do in your own home (kit is sent to you or a coach), there are over 50 genetic markers that are reported which indicate potential in strength, aerobic capacity, responses to various types of training, ability to recover, injury potential in various parts of the body, and sport psychology attributes toward training and athletics in general.
Funding History
| December 2015 | $1.6M |
|---|
Management
Founder/CEO
Jeremy Koenig
Press
- Mar, 15 2016
Baylor Football Teams Up With Athletigen to Incorporate Genetics into Athlete Performance- Jan, 26 2016
Top Track And Field Performance Center Partners With Sports Genetics Analysis Company To Reach New Levels Of Athlete Training- Jan, 4 2016
Holiday Funding Roundup: Axios, Athletigen- Jan, 4 2016
StrictlyVC: January 4, 2016EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
